Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. [electronic resource]
Producer: 20190603Description: 274-285 p. digitalISSN:- 1873-2968
- ATP Binding Cassette Transporter, Subfamily B -- antagonists & inhibitors
- ATP Binding Cassette Transporter, Subfamily G, Member 2 -- antagonists & inhibitors
- Aminopyridines -- pharmacology
- Antineoplastic Agents -- pharmacology
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm -- drug effects
- HEK293 Cells
- Humans
- Neoplasm Proteins -- antagonists & inhibitors
- Pyrroles -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.